Related Experiment Video
Updated: Feb 21, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Molecular autopsy of sudden unexplained deaths reveals genetic predispositions for cardiac diseases among young
Nicole Hellenthal1, Anna Gaertner-Rommel2, Bärbel Klauke2
1Universitätsklinikum Hamburg Eppendorf, Institut für Rechtsmedizin, Butenfeld 34, D-22529 Hamburg, Germany.
Insights
Genetic testing identified underlying heart conditions in 80% of young sudden unexplained death victims. This molecular autopsy approach aids in preventing further family deaths.
Area of Science:
- Forensic pathology
- Cardiovascular genetics
- Molecular diagnostics
Background:
- Sudden cardiac death (SCD) in younger individuals (<35 years) often stems from genetic cardiomyopathies and arrhythmogenic disorders.
- Identifying the genetic cause of death is crucial for preventing further fatalities within affected families.
Observation:
- A study examined 10 forensic cases of sudden unexplained death (SUD) in victims aged 19-40.
- Next-generation sequencing of 174 candidate genes was performed on DNA from these victims.
Findings:
- Genetic disposition for heart disease was found in 80% (8/10) of SUD cases.
- Pathogenic mutations were identified in 3 cases, and variants of uncertain significance in 5 cases.
- Family screening revealed two additional mutation carriers.
Implications:
- Molecular genetics significantly enhances post-mortem diagnosis of fatal genetic heart diseases in SUD victims.
- Integrating molecular genetics into routine forensic and pathological practice is recommended for improved diagnostic yield and family-specific prevention strategies.
Aims:
Coronary artery disease accounts for the majority of sudden cardiac deaths (SCD) in the older population whereas cardiomyopathies and arrhythmogenic abnormalities predominate in younger SCD victims (<35 years) with a significant genetic component. The elucidation of the pathogenetic cause of death might be relevant for the prevention of further deaths within affected families. Aim of this study was to determine the portion of underlying genetic heart diseases among unexplained putative SCD cases from a large German forensic department.
Methods And Results:
We included 10 forensic cases of sudden unexplained death (SUD) victims aged 19-40 years, who died by SCD due to forensic autopsy. DNA was analysed by next generation panel sequencing of 174 candidate genes for channelopathies and cardiomyopathies. Cardiological examinations, genetic counselling, and subsequent genetic testing were offered to all affected families. We identified within 1 year 10 cases of SUD among 172 forensic cases. Evidence for a genetic disposition was found in 8 of 10 (80%) cases, with pathogenic mutations in 3 and variants of uncertain significance in 5 of SCD cases. Subsequent selective screening of family members revealed two additional mutation carriers.
Conclusion:
The study provides strong evidence that molecular genetics improves the post mortem diagnosis of fatal genetic heart diseases among SUD victims. Molecular genetics should be integrated in forensic and pathological routine practice.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
10:53Dissection Techniques and Histological Sampling of the Heart in Large Animal Models for Cardiovascular Diseases
Published on: June 16, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy I: Introduction and Classification